La TFDA homologue NaoTrac, le premier robot de navigation neurochirurgicale autonome de Brain Navi Biotechnology ...Middle East

PR Newswire - Economy
La TFDA homologue NaoTrac, le premier robot de navigation neurochirurgicale autonome de Brain Navi Biotechnology
HSINCHU, 8 août 2022 /PRNewswire/ -- NaoTrac, le robot de navigation neurochirurgical certifié CE, a obtenu l'approbation de la Taiwan's Food and Drug Administration (TFDA) en juillet 2022, et sa soumission à la FDA (U.S. Food and Drug Administration) pour autorisation est prévue pour la...

Hence then, the article about la tfda homologue naotrac le premier robot de navigation neurochirurgicale autonome de brain navi biotechnology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( La TFDA homologue NaoTrac, le premier robot de navigation neurochirurgicale autonome de Brain Navi Biotechnology )

Apple Storegoogle play

Last updated :

Also on site :



Latest News